LGNDLIGAND PHARMACEUTICALS INC同业对比
LIGAND PHARMACEUTICALS INC 与SIC 2834 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LGND本股 | $5.6B#6 | 29.0x#2 | 5.8x#8 | 21.0x#5 | 60.4%#4 | 3186.6%#1 | 15.3%#2 | 12.9%#3 | 3.0%#3 | — | 70.3%#8 | — |
| TVTX | $6.0B#1 | — | 246.6x#13 | 12.3x#4 | 110.5%#3 | 92.1%#4 | -12.8%#5 | -104.2%#14 | — | — | — | — |
| GOSS | $5.9B#2 | — | — | 121.8x#8 | -57.7%#9 | -201.4%#15 | -352.2%#9 | — | — | — | — | — |
| AMRN | — | — | — | — | -6.5%#8 | 55.4%#6 | -23.5%#6 | -8.7%#7 | -16.2%#4 | — | -7.3%#12 | — |
| AMRX | $5.8B#3 | 37.8x#3 | 175.5x#12 | 1.9x#1 | 8.0%#7 | 161.6%#3 | 13.1%#3 | 218.2%#1 | 14.6%#1 | 6#1 | 88.8%#7 | — |
| COGT | $5.7B#4 | — | 10.8x#9 | 727.7x#9 | -65.0%#10 | -28.6%#11 | -4235.3%#10 | -61.8%#13 | -84.3%#8 | — | 167.2%#5 | — |
| DNTH | $5.6B#7 | — | 4.8x#6 | 2753.9x#11 | -67.3%#11 | -91.1%#13 | -8739.3%#12 | -13.9%#9 | — | — | 157.8%#6 | — |
| PTCT | $5.6B#5 | — | — | 3.3x#2 | 114.5%#2 | 288.0%#2 | 50.1%#1 | — | — | — | 11.4%#11 | — |
| XENE | $5.6B#8 | — | 4.5x#4 | 740.8x#10 | — | -47.6%#12 | -4974.3%#11 | -27.8%#11 | -32.5%#6 | — | 56.4%#9 | — |
| ERAS | $5.3B#9 | — | 14.7x#11 | — | — | 23.0%#7 | — | -34.4%#12 | — | — | 814.7%#1 | — |
| EWTX | $5.0B#10 | — | 11.1x#10 | — | — | -25.4%#10 | — | -0.0%#5 | -50.9%#7 | — | 228.9%#2 | — |
| PBLS | $4.9B#11 | — | 4.7x#5 | — | — | — | — | 0.0%#4 | — | — | — | — |
| ACAD | $4.7B#12 | 12.3x#1 | 3.6x#1 | 4.4x#3 | 11.9%#6 | 73.0%#5 | 9.8%#4 | 29.9%#2 | 11.4%#2 | — | 13.2%#10 | — |
| MANE | $4.5B#13 | — | 5.5x#7 | — | — | -164.3%#14 | — | -8.6%#6 | — | — | — | — |
| TNGX | $4.0B#14 | — | 3.9x#2 | 64.3x#7 | 48.3%#5 | 22.0%#8 | -178.4%#7 | -9.9%#8 | — | — | 212.2%#3 | — |
| ABCL | $3.9B#15 | — | 4.4x#3 | 52.0x#6 | 160.6%#1 | 10.1%#9 | -289.0%#8 | -16.3%#10 | -28.0%#5 | — | 179.3%#4 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-17。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议